Sign In / Join

close

Clinical Trials

Our Clinical Trials articles highlight top clinical trials, their results, and how patients can participate in them.

Headlines All Categories Treatment Advances Navigating Your Health Core Education Patient Stories HealthTree Research Conferences Clinical Trials HealthTree Programs HealthTree Press

Recent Articles

New CAR T for Relapsed/Refractory Myeloma Shows Promising Phase 1 Results

October 14, 2024

Learn about anitocabtagene autoleucel, a new CAR-T treatment for relapsed myeloma patients, showing promising results in Phase I trials.

What are Clinical Trials, and How May They Help Me?

September 30, 2024

Learn about clinical trials to open the door to accessing innovative cancer treatments.

Can Yoga Help Myeloma Patients on Active Treatment?

August 29, 2024

Explore how yoga can improve physical and mental health for myeloma patients in a national clinical trial by the University of Arizona.

First R/R Myeloma Patient Treated with New BCMA-Directed Bispecific Antibody in Phase 3 Study

June 21, 2024

Learn about a new BCMA-directed bispecific antibody called ABBV-383, administered to relapsed/refractory myeloma patients in a clinical trial.

The Use of Bispecifics and CAR-T in Myeloma Treatment

May 21, 2024

The Use of Bispecifics And CAR-T In Myeloma Treatment

Ensuring Access to Myeloma Research, with Dr. Gurbakhash Kaur

May 07, 2024

Watch our interview with Dr. Kaur. She shared the comprehensive myeloma research program at UT Southwestern.

ORIC-533 : A New Small Molecule to Treat Multiple Myeloma

April 26, 2024

Learn about ORIC-533, a potential new oral treatment for myeloma. Understand how it works, early clinical trial results, and the future outlook for this drug.

How CAR-T Therapy is Changing the Treatment Landscape for Myeloma

April 18, 2024

Simmons Cancer Center leads Myeloma research with CAR-T, stem cells & more. Learn about GPRC5D targeting, Tregs, bispecific antibodies & upcoming trials.

ASH 2023: Understanding Outcomes of CAR T in Extramedullary Multiple Myeloma

January 18, 2024

What are the outcomes following CAR T-cell therapy in multiple myeloma patients with extramedullary and paramedullary disease?

LBL-034: A New Option for Myeloma Patients in Clincal Trial Stage

August 24, 2023

Nanjing Leads Biolabs is starting a new clinical trial for a myeloma bi-specific antibody targeting GPRC5D.

Upcoming Events

Bi-Monthly Blood Cancer Financial Q&A: Expert Answers to Your Treatment Costs and Support Questions

Dec 03 / 13:00 EST

Learn About HealthTree Regional Cure Teams & How You Can Get Involved - NorthEast, Southeast and Midwest Region

Dec 05 / 13:00 EST

New Discoveries in Multiple Myeloma with Dr. Brian Van Ness from the University of Minnesota

Jan 06 / 12:00 MST

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Clinical Trials

Recent Articles

New CAR T for Relapsed/Refractory Myeloma Shows Promising Phase 1 Results

What are Clinical Trials, and How May They Help Me?

Can Yoga Help Myeloma Patients on Active Treatment?

First R/R Myeloma Patient Treated with New BCMA-Directed Bispecific Antibody in Phase 3 Study

The Use of Bispecifics and CAR-T in Myeloma Treatment

Ensuring Access to Myeloma Research, with Dr. Gurbakhash Kaur

ORIC-533 : A New Small Molecule to Treat Multiple Myeloma

How CAR-T Therapy is Changing the Treatment Landscape for Myeloma

ASH 2023: Understanding Outcomes of CAR T in Extramedullary Multiple Myeloma

LBL-034: A New Option for Myeloma Patients in Clincal Trial Stage

Trending Articles

When Does Smoldering Myeloma Become Active Myeloma?

What Is the Prognosis of a Multiple Myeloma Patient?

What Is the Best Consolidation/Maintenance Therapy for People with Myeloma?

A Myeloma Caregiver’s Journey: Barb Mower’s Practical Insights and Hard-Earned Advice

New Treatment Coming for High-Risk Smoldering Myeloma?

Upcoming Events

Bi-Monthly Blood Cancer Financial Q&A: Expert Answers to Your Treatment Costs and Support Questions

Learn About HealthTree Regional Cure Teams & How You Can Get Involved - NorthEast, Southeast and Midwest Region

New Discoveries in Multiple Myeloma with Dr. Brian Van Ness from the University of Minnesota

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Follow Us

Education

Community

Cure Hub

Get Involved

About us

Need Help?

Legal Info

Clinical Trials

Recent Articles

New CAR T for Relapsed/Refractory Myeloma Shows Promising Phase 1 Results

What are Clinical Trials, and How May They Help Me?

Can Yoga Help Myeloma Patients on Active Treatment?

First R/R Myeloma Patient Treated with New BCMA-Directed Bispecific Antibody in Phase 3 Study

The Use of Bispecifics and CAR-T in Myeloma Treatment

Ensuring Access to Myeloma Research, with Dr. Gurbakhash Kaur

ORIC-533 : A New Small Molecule to Treat Multiple Myeloma

How CAR-T Therapy is Changing the Treatment Landscape for Myeloma

ASH 2023: Understanding Outcomes of CAR T in Extramedullary Multiple Myeloma

LBL-034: A New Option for Myeloma Patients in Clincal Trial Stage

Trending Articles

When Does Smoldering Myeloma Become Active Myeloma?

What Is the Prognosis of a Multiple Myeloma Patient?

What Is the Best Consolidation/Maintenance Therapy for People with Myeloma?

A Myeloma Caregiver’s Journey: Barb Mower’s Practical Insights and Hard-Earned Advice

New Treatment Coming for High-Risk Smoldering Myeloma?

Upcoming Events

Bi-Monthly Blood Cancer Financial Q&A: Expert Answers to Your Treatment Costs and Support Questions

Learn About HealthTree Regional Cure Teams & How You Can Get Involved - NorthEast, Southeast and Midwest Region

New Discoveries in Multiple Myeloma with Dr. Brian Van Ness from the University of Minnesota

Get the latest thought leadership on your Multiple Myeloma delivered straight to your inbox

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Follow Us

Education

Community

Cure Hub

Get Involved

About us

Need Help?

Legal Info